Cargando…
Plastic Surgeons Defend Textured Breast Implants at 2019 U.S. Food and Drug Administration Hearing: Why It Is Time to Reconsider
Textured breast implants were the subject of a U.S. Food and Drug Administration (FDA) hearing on March 25 and 26, 2019. Regulating agencies in other countries, including all of Europe and Canada, have already banned macrotextured implants. Patients affected by Breast Implant-Associated Anaplastic L...
Autor principal: | Swanson, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756678/ https://www.ncbi.nlm.nih.gov/pubmed/31592028 http://dx.doi.org/10.1097/GOX.0000000000002410 |
Ejemplares similares
-
Caprini Scores, Risk Stratification, and Rivaroxaban in Plastic Surgery: Time to Reconsider Our Strategy
por: Swanson, Eric
Publicado: (2016) -
Analysis of Trends in the Selection and Production of U.S. Academic Plastic Surgery Faculty
por: Daneshgaran, Giulia, et al.
Publicado: (2020) -
Coronavirus Disease 2019 State Guidelines on Elective Surgery: Considerations for Plastic and Reconstructive Surgeons
por: Sarac, Benjamin A., et al.
Publicado: (2020) -
Plastic Surgery and Suicide: A Clinical Guide for Plastic Surgeons
por: Reddy, Vikram, et al.
Publicado: (2016) -
The Utility of a Master of Business Administration Degree in Plastic Surgery: Determining Motivations and Outcomes of a Formal Business Education Among Plastic Surgeons
por: Lee, Cody S., et al.
Publicado: (2018)